Certolizumab pegol vs Canakinumab

Interacting Drugs
Certolizumab pegol
vs
Canakinumab
Security Level
Major, Avoid combination
Mechanism
Canakinumab: Anti-TNF Agents may enhance the adverse/toxic effect of Canakinumab. Specifically, the risk for serious infections and/or neutropenia may be increased.
Management
Avoid combination

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Certolizumab pegol vs Canakinumab


Other Interactions of Certolizumab pegol

We are Developing Our database, More results coming soon.

Other Interactions of Canakinumab

We are Developing Our database, More results coming soon.